Preferred Label : Elzonris;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3281016/fr/elzonris-tagraxofusp
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
tagraxofusp
Elzonris
Product containing only tagraxofusp in parenteral dose form (medicinal product form)
infusions, intravenous
tagraxofusp
adult
Blastic Plasmacytoid Dendritic Cell Neoplasm
histiocytic disorders, malignant
antineoplastic agents
evaluation of the transparency committee

---
Nous contacter.
08/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.